NRIX
Price
$25.61
Change
+$0.46 (+1.83%)
Updated
Sep 17, 01:24 PM (EDT)
Capitalization
2.61B
22 days until earnings call
Intraday BUY SELL Signals
TPST
Price
$0.89
Change
-$0.32 (-26.45%)
Updated
Sep 17, 02:13 PM (EDT)
Capitalization
20.01M
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRIX vs TPST

NRIX vs TPST Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NRIX vs. TPST commentary
Sep 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and TPST is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($2.61B) has a higher market cap than TPST($20M). NRIX YTD gains are higher at: 32.578 vs. TPST (-57.840). TPST has higher annual earnings (EBITDA): -40.22M vs. NRIX (-343.92M). NRIX has more cash in the bank: 444M vs. TPST (779K). TPST has less debt than NRIX: TPST (7.56M) vs NRIX (58.1M). NRIX has higher revenues than TPST: NRIX (36.8M) vs TPST (0).
NRIXTPSTNRIX / TPST
Capitalization2.61B20M13,055%
EBITDA-343.92M-40.22M855%
Gain YTD32.578-57.840-56%
P/E RatioN/AN/A-
Revenue36.8M0-
Total Cash444M779K56,996%
Total Debt58.1M7.56M769%
FUNDAMENTALS RATINGS
NRIX vs TPST: Fundamental Ratings
NRIX
TPST
OUTLOOK RATING
1..100
7198
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
68
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3593
P/E GROWTH RATING
1..100
10084
SEASONALITY SCORE
1..100
8565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NRIX's Valuation (47) in the null industry is in the same range as TPST (68) in the Pharmaceuticals Major industry. This means that NRIX’s stock grew similarly to TPST’s over the last 12 months.

NRIX's Profit vs Risk Rating (100) in the null industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that NRIX’s stock grew similarly to TPST’s over the last 12 months.

NRIX's SMR Rating (98) in the null industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that NRIX’s stock grew similarly to TPST’s over the last 12 months.

NRIX's Price Growth Rating (35) in the null industry is somewhat better than the same rating for TPST (93) in the Pharmaceuticals Major industry. This means that NRIX’s stock grew somewhat faster than TPST’s over the last 12 months.

TPST's P/E Growth Rating (84) in the Pharmaceuticals Major industry is in the same range as NRIX (100) in the null industry. This means that TPST’s stock grew similarly to NRIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NRIXTPST
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 24 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Sep 17, 2026
Stock price -- (NRIX: $25.15 vs. TPST: $1.21)
Brand notoriety: NRIX and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 107% vs. TPST: 4267%
Market capitalization -- NRIX: $2.61B vs. TPST: $20.01M
NRIX [@Biotechnology] is valued at $2.61B. TPST’s [@Biotechnology] market capitalization is $20.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.09B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 0 FA rating(s) are green while TPST’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 0 green, 5 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than TPST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 6 bullish TA indicator(s).

  • NRIX’s TA Score: 4 bullish, 4 bearish.
  • TPST’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TPST is a better buy in the short-term than NRIX.

Price Growth

NRIX (@Biotechnology) experienced а -4.23% price change this week, while TPST (@Biotechnology) price change was +33.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.46%. For the same industry, the average monthly price growth was -4.59%, and the average quarterly price growth was +7.82%.

Reported Earning Dates

NRIX is expected to report earnings on Oct 09, 2026.

TPST is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-0.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
NRIX
Daily Signal:
Gain/Loss:
TPST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LGPS0.830.05
+6.60%
LogProstyle Inc
ELV412.56-4.98
-1.19%
Elevance Health
TV2.19-0.06
-2.67%
Grupo Televisa SA
DLB58.74-1.62
-2.68%
Dolby Laboratories IncClass A
IVVD0.81-0.02
-2.98%
Invivyd